Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Municipal Finance topic
No spam. Unsubscribe anytime.
Coconut Creek commission approves consent agenda including opioid settlements and budget reimbursement; crossing guard item pulled for discussion
Summary
The City Commission approved minutes, meeting cancellations and several resolutions on opioid litigation settlements, a Purdue Pharma plan participation and a bond reimbursement policy. A separate contract for school crossing guard services was pulled for discussion and approved after presentation.
The Coconut Creek City Commission on Sept. 11 approved most items on its consent agenda, including participation in opioid-related litigation settlements and authorization to reimburse certain capital costs from future bond proceeds. Commissioners also approved minutes from prior meetings and canceled two regular meetings later this year.
The consent agenda passed on a roll call vote with Commissioners Riedell, Welch, Brody, Vice Mayor Wasserman and Mayor Railey voting yes. Commissioner Bridal initially pulled one consent item — a contract for school crossing guard services — for discussion; after a presentation and questions the commission approved that item as well.
Why it matters: The resolutions authorize the city manager to execute settlement agreements and other documents that affect the city’s financial and legal exposure, and they permit reimbursement of capital costs from future bond issues — a standard municipal financing action that preserves flexibility for upcoming projects.
What commissioners approved:
- Approval of minutes for meetings labeled 2025-0807R and 2025-0811WS (no discussion).
- Cancellation of the Nov. 27 and Dec. 25, 2025 regular City Commission meetings (no discussion).
- Resolution 2025-1136 (listed in the meeting as “two-twenty five-one 136”): authorizing participation in eight opioid-related litigation settlements with named manufacturers and authorizing the city manager to execute the necessary agreements.
- Resolution 2025-1137 (listed as “two-twenty five-one 137”): authorizing participation in a direct settlement agreement and to vote in favor of an amendment to the Purdue Pharma LP chapter 11 plan of reorganization.
- Resolution (listed as “two-twenty five-one 140/401” in the packet): authorizing reimbursement of certain capital costs from future bond proceeds for various capital improvement projects.
Votes: The roll call for the initial motion approving items 2, 3, 4, 5 and 7 was unanimous in favor (Riedell, Welch, Brody, Wasserman, Railey). Item 6 (crossing guard services) was pulled for discussion and later approved unanimously after presentation and questions.
Meeting context: The crossing guard contract (item 6) attracted questions from several commissioners and drew a vendor representative to the meeting; that discussion is covered in a separate article. The commission did not amend the opioid or Purdue-related resolutions during this meeting.
Ending: The commission moved on to other agenda items after the consent votes. The minutes and resolutions approved at this meeting give staff authority to complete the listed settlements and financial steps without returning to the dais for additional approval unless otherwise required by the documents themselves.
